Prezzo di chiusura
Altri mercati azionari
|
||
- USD | - |
|
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
DNA Medicines
100,0
%
| 10 | 100,0 % | 1 | 100,0 % | -91,89% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 1 | 100,0 % | -91,89% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 25/03/19 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 01/06/02 |
Chief Tech/Sci/R&D Officer | - | 01/02/07 | |
Jeffrey Skolnik
CTO | Chief Tech/Sci/R&D Officer | - | 12/10/16 |
Michael Sumner
CTO | Chief Tech/Sci/R&D Officer | 59 | 27/06/22 |
Laurent Humeau
CTO | Chief Tech/Sci/R&D Officer | 57 | 18/02/14 |
Thomas Hong
IRC | Investor Relations Contact | - | - |
Cheryl Elder
LAW | General Counsel | - | - |
Shawn D. Bridy
PRN | Corporate Officer/Principal | - | 24/05/18 |
Maggie Campbell
AUD | Comptroller/Controller/Auditor | - | 01/03/06 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 01/12/03 |
Lota Zoth
BRD | Director/Board Member | 64 | 01/01/18 |
Jay Shepard
BRD | Director/Board Member | 66 | 15/01/20 |
Wendy Yarno
BRD | Director/Board Member | 68 | 06/12/17 |
David Weiner
FOU | Founder | 67 | 29/06/83 |
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 25/03/19 |
Roger Dansey
BRD | Director/Board Member | 67 | 13/05/21 |
Ann Miller
BRD | Director/Board Member | 66 | 25/03/19 |
Coordinate società
Inovio Pharmaceuticals, Inc.
660 West Germantown Pike Suite 110
19462-1111, Plymouth Meeting
+267 440 4200
http://www.inovio.com![Indirizzo Inovio Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/15388.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+22,10% | 46,55 Mrd | |
+46,45% | 41,84 Mrd | |
-3,12% | 40,84 Mrd | |
+36,10% | 32,95 Mrd | |
-6,30% | 28,27 Mrd | |
+18,71% | 27,78 Mrd | |
+46,15% | 14,26 Mrd | |
+44,52% | 13,69 Mrd | |
+0,19% | 12,18 Mrd |
- Borsa valori
- Azioni
- Azione INO
- Azione
- Società Inovio Pharmaceuticals Inc